Literature DB >> 11144388

Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes.

A Dilraj1, F T Cutts, J V Bennett, J Fernandez de Castro, B Cohen, H M Coovadia.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11144388     DOI： 10.1097/00006454-200012000-00021

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  4 in total

1.  Relevance of a pre-existing measles immunity prior immunization with a recombinant measles virus vector.

Authors:  Marlyse C Knuchel; René R Marty; Teldja Neige Azzouz Morin; Orhan Ilter; Armando Zuniga; Hussein Y Naim
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

Review 2.  Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies.

Authors:  Melissa M Coughlin; Andrew S Beck; Bettina Bankamp; Paul A Rota
Journal:  Viruses       Date:  2017-01-19       Impact factor: 5.048

3.  Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein.

Authors:  Nicolas Escriou; Benoît Callendret; Valérie Lorin; Chantal Combredet; Philippe Marianneau; Michèle Février; Frédéric Tangy
Journal:  Virology       Date:  2014-01-28       Impact factor: 3.616

4.  Local and systemic immune responses to intratracheal instillation of antigen and DNA vaccines in mice.

Authors:  Catherine Lombry; Aline Marteleur; Mohammed Arras; Dominique Lison; Jamila Louahed; Jean-Christophe Renauld; Véronique Préat; Rita Vanbever
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.580
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.